Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • yumiya
    Junior Member
    • Oct 2011
    • 3

    #1

    Mapped onto pseudogenes?

    I have a problem in TopHat-Cufflinks pipeline. I want to get splicing information of a gene family, but the annotation is bad so far, that is, nothing is annotated or huge exons are annotated.
    This family has a number of processed pseudogenes with almost same sequence. It seems that reads that are supposed to be mapped onto "real" genes are mapped onto these pseudogenes.
    Now, I have a gff file defining the location of those pseudogenes in the genome. Is there a way to mask these pseudogenes in TopHat mapping?
    I do not think -M option in Cufflinks works for me, because the reads are already mapped in .bam file from TopHat.
    I really need help. If someone knows, please tell me
  • yumiya
    Junior Member
    • Oct 2011
    • 3

    #2
    Masking

    I masked pseudogenes on the genome with "NNNNN....".
    That worked at least partly.

    Comment

    • Dario1984
      Senior Member
      • Jun 2011
      • 166

      #3
      Some pseduogenes are transcribed, though. So, this isn't a good solution, either. It's a problem for us, too. We get lots of poor transcript assemblies because of this.

      Comment

      • yumiya
        Junior Member
        • Oct 2011
        • 3

        #4
        Yes, that's true, but in our case we know that expression of pseudogenes is at a very low level compared to real genes. Moreover, our goal is qualitative rather than quantitative, that is, identification of alternative isoforms.
        If I find alternative isoforms in some genes, I can go back to the masked pseudogenes to see whether they might give the identified isoforms (I am talking about "processed" pseudogenes).
        However, masking is of course not a good solution for quantitative analyses...

        By the way, I found another key. If you are using TopHat and your target genes are highly expressed, --initial-read-mismatches should be 0. Minimize loss of reads derived from true genes by pseudogenes in initial mapping with this option.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          Yesterday, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 02:55 AM
        0 responses
        9 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        12 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        24 views
        0 reactions
        Last Post SEQadmin2  
        Working...